The Value of Diagnostic Information in Heart Failure – 2-pager
A case study, conducted by MedTech Europe, explores how the use of information generated by In-Vitro Diagnostics, such as cardiac biomarkers, can address current shortcomings in Heart Failure care (e.g. missed or late diagnosis and ineffective monitoring), The study also calls on policymakers across Europe to better leverage this value and hence improve care plans for Heart Failure patients.
Developed in collaboration with Executive Insight.
Posted on 31.03.2020Back to the campaign